| NCT04456959 |
InO - A Retrospective Study of UK Patients With Leukaemia |
https://ClinicalTrials.gov/show/NCT04456959 |
Recruiting |
Pfizer |
2020-12-31 |
| NCT04454580 |
Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy |
https://ClinicalTrials.gov/show/NCT04454580 |
Recruiting |
Ospedale Maggiore Di Trieste |
2020-07-23 |
| NCT03627208 |
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch |
https://ClinicalTrials.gov/show/NCT03627208 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2021-12-31 |
| NCT03374137 |
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03374137 |
Recruiting |
Hoffmann-La Roche |
2020-09-30 |
| NCT03342144 |
Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting |
https://ClinicalTrials.gov/show/NCT03342144 |
Recruiting |
AbbVie |
2022-12-31 |
| NCT03316456 |
Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction |
https://ClinicalTrials.gov/show/NCT03316456 |
Completed |
Masonic Cancer Center, University of Minnesota |
2017-12-26 |
| NCT03311815 |
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia. |
https://ClinicalTrials.gov/show/NCT03311815 |
Recruiting |
PETHEMA Foundation |
2020-09-30 |
| NCT03289182 |
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT03289182 |
Active, not recruiting |
Hoffmann-La Roche |
2020-10-26 |
| NCT03284593 |
Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition |
https://ClinicalTrials.gov/show/NCT03284593 |
Active, not recruiting |
University Hospital, Toulouse |
2030-12-31 |
| NCT03279900 |
Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy |
https://ClinicalTrials.gov/show/NCT03279900 |
Completed |
Indonesia University |
2018-05-16 |
| NCT03260101 |
Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study |
https://ClinicalTrials.gov/show/NCT03260101 |
Recruiting |
Cellect Biotechnology |
2021-12-31 |
| NCT03253848 |
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03253848 |
Recruiting |
Eastern Cooperative Oncology Group |
2022-08-18 |
| NCT03251352 |
TKI Discontinuation in CML Patients of China |
https://ClinicalTrials.gov/show/NCT03251352 |
Recruiting |
Shenzhen Second People’s Hospital |
2020-09-30 |
| NCT03226704 |
Leukapheresis for CAR-Therapy Manufacturing |
https://ClinicalTrials.gov/show/NCT03226704 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-05-01 |
| NCT03233763 |
Laboratory Studies Into the Pathology of Leukaemia |
https://ClinicalTrials.gov/show/NCT03233763 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2021-02-01 |
| NCT03190499 |
Quality of Life in Children With Cancer |
https://ClinicalTrials.gov/show/NCT03190499 |
Completed |
Cumhuriyet University |
2018-08-01 |
| NCT03123887 |
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL |
https://ClinicalTrials.gov/show/NCT03123887 |
Completed |
Harbin Hematology and Oncology Institute |
2016-06-03 |
| NCT03075969 |
Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03075969 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-03-16 |
| NCT03067584 |
Genetic Study of Familial Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03067584 |
Completed |
St. Jude Children’s Research Hospital |
2017-06-23 |
| NCT03058588 |
Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes |
https://ClinicalTrials.gov/show/NCT03058588 |
Recruiting |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2021-02-09 |
| NCT03059251 |
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina |
https://ClinicalTrials.gov/show/NCT03059251 |
Completed |
Hoffmann-La Roche |
2019-03-30 |
| NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
https://ClinicalTrials.gov/show/NCT03050268 |
Recruiting |
St. Jude Children’s Research Hospital |
2037-03-31 |
| NCT03045120 |
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States |
https://ClinicalTrials.gov/show/NCT03045120 |
Recruiting |
Bristol-Myers Squibb |
2021-01-31 |
| NCT03000335 |
Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk |
https://ClinicalTrials.gov/show/NCT03000335 |
Recruiting |
Curewize Health Ltd. |
2020-05-31 |
| NCT02991066 |
Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02991066 |
Recruiting |
First Affiliated Hospital of Harbin Medical University |
2019-12-31 |
| NCT02981784 |
Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I |
https://ClinicalTrials.gov/show/NCT02981784 |
Completed |
Hospices Civils de Lyon |
2011-12-31 |
| NCT02977312 |
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan |
https://ClinicalTrials.gov/show/NCT02977312 |
Completed |
Hikma Pharmaceuticals LLC |
2015-02-28 |
| NCT02921815 |
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment |
https://ClinicalTrials.gov/show/NCT02921815 |
Active, not recruiting |
Celgene |
2020-06-19 |
| NCT02927106 |
Beat AML Core Study |
https://ClinicalTrials.gov/show/NCT02927106 |
Recruiting |
University of Florida |
2024-02-15 |
| NCT02899767 |
Transfusion in Adult Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02899767 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02900430 |
Invasives Aspergillosis in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02900430 |
Completed |
University Hospital, Brest |
2015-12-31 |
| NCT02896829 |
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02896829 |
Completed |
University Hospital, Bordeaux |
2019-04-30 |
| NCT02895542 |
Preparatory Work to Assess Adherence to Oral Chemotherapy |
https://ClinicalTrials.gov/show/NCT02895542 |
Completed |
Wake Forest University Health Sciences |
2017-04-28 |
| NCT02891551 |
An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands |
https://ClinicalTrials.gov/show/NCT02891551 |
Completed |
Celgene |
2016-06-30 |
| NCT02883946 |
Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study |
https://ClinicalTrials.gov/show/NCT02883946 |
Completed |
CHU de Reims |
2013-02-28 |
| NCT02888977 |
Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL |
https://ClinicalTrials.gov/show/NCT02888977 |
Recruiting |
Versailles Hospital |
2020-12-31 |
| NCT02869256 |
Regional Central Database Recording of Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02869256 |
Recruiting |
Institut Bergonié |
2024-01-31 |
| NCT02861651 |
Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing |
https://ClinicalTrials.gov/show/NCT02861651 |
Completed |
Institut Paoli-Calmettes |
2015-07-31 |
| NCT02859389 |
Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome |
https://ClinicalTrials.gov/show/NCT02859389 |
Completed |
St. Jude Children’s Research Hospital |
2019-01-31 |
| NCT02845232 |
Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly |
https://ClinicalTrials.gov/show/NCT02845232 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02844257 |
Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia |
https://ClinicalTrials.gov/show/NCT02844257 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02844218 |
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02844218 |
Completed |
Hospices Civils de Lyon |
2014-12-31 |
| NCT02842229 |
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms |
https://ClinicalTrials.gov/show/NCT02842229 |
Completed |
Celgene |
2017-02-02 |
| NCT02842112 |
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02842112 |
Completed |
Hospices Civils de Lyon |
2013-12-31 |
| NCT02827617 |
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02827617 |
Recruiting |
Oncology Institute of Southern Switzerland |
2021-02-28 |
| NCT02823132 |
Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia |
https://ClinicalTrials.gov/show/NCT02823132 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-06-30 |
| NCT02783651 |
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US |
https://ClinicalTrials.gov/show/NCT02783651 |
Completed |
Amgen |
2020-03-31 |
| NCT02774850 |
Home Away From Home - Medical Outcomes |
https://ClinicalTrials.gov/show/NCT02774850 |
Completed |
Children’s Hospital of Philadelphia |
2019-07-26 |
| NCT02767388 |
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery |
https://ClinicalTrials.gov/show/NCT02767388 |
Completed |
University of Nebraska |
2017-12-11 |
| NCT02759822 |
Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias |
https://ClinicalTrials.gov/show/NCT02759822 |
Recruiting |
Instituto Nacional de Cancer, Brazil |
2021-04-30 |
| NCT02734823 |
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor |
https://ClinicalTrials.gov/show/NCT02734823 |
Recruiting |
University of Southern California |
2020-03-01 |
| NCT02714790 |
Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02714790 |
Completed |
Azienda Ospedaliera Città della Salute e della Scienza di Torino |
2015-06-30 |
| NCT02693899 |
Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia |
https://ClinicalTrials.gov/show/NCT02693899 |
Completed |
Nantes University Hospital |
2018-02-06 |
| NCT02677064 |
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia |
https://ClinicalTrials.gov/show/NCT02677064 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT02667093 |
Samples From Leukemia Patients and Their Donors to Identify Specific Antigens |
https://ClinicalTrials.gov/show/NCT02667093 |
Active, not recruiting |
PersImmune, Inc |
2020-12-31 |
| NCT02662920 |
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML) |
https://ClinicalTrials.gov/show/NCT02662920 |
Completed |
Wake Forest University Health Sciences |
2014-04-30 |
| NCT02631993 |
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia |
https://ClinicalTrials.gov/show/NCT02631993 |
Completed |
Karolinska University Hospital |
2014-11-30 |
| NCT02617004 |
Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults |
https://ClinicalTrials.gov/show/NCT02617004 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-12-31 |
| NCT02606825 |
VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years |
https://ClinicalTrials.gov/show/NCT02606825 |
Completed |
PETHEMA Foundation |
2018-02-15 |
| NCT02598752 |
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation |
https://ClinicalTrials.gov/show/NCT02598752 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-04-10 |
| NCT02582320 |
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program |
https://ClinicalTrials.gov/show/NCT02582320 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT00923442 |
Biology Studies of Hematologic Cancers |
https://ClinicalTrials.gov/show/NCT00923442 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01351545 |
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) |
https://ClinicalTrials.gov/show/NCT01351545 |
Recruiting |
Center for International Blood and Marrow Transplant Research |
2021-10-31 |
| NCT00559065 |
A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China |
https://ClinicalTrials.gov/show/NCT00559065 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00342888 |
Case-Control Study of Pesticides and Childhood Leukemia |
https://ClinicalTrials.gov/show/NCT00342888 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02560883 |
Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes |
https://ClinicalTrials.gov/show/NCT02560883 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2025-12-31 |
| NCT00268528 |
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission |
https://ClinicalTrials.gov/show/NCT00268528 |
Completed |
Children’s Oncology Group |
2012-03-05 |
| NCT02559583 |
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin’s Lymphoma (NHL) in Latin America |
https://ClinicalTrials.gov/show/NCT02559583 |
Completed |
Janssen-Cilag Ltd. |
2016-06-30 |
| NCT02546791 |
Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study |
https://ClinicalTrials.gov/show/NCT02546791 |
Completed |
Bristol-Myers Squibb |
2016-11-30 |
| NCT02028650 |
Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation |
https://ClinicalTrials.gov/show/NCT02028650 |
Completed |
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
2013-02-28 |
| NCT02527447 |
Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15) |
https://ClinicalTrials.gov/show/NCT02527447 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-05-10 |
| NCT02520895 |
Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02520895 |
Completed |
Hospices Civils de Lyon |
2013-10-31 |
| NCT02491398 |
Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02491398 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-10-31 |
| NCT02461316 |
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02461316 |
Completed |
Hoffmann-La Roche |
2011-12-31 |
| NCT02455024 |
An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® |
https://ClinicalTrials.gov/show/NCT02455024 |
Recruiting |
Takeda |
2020-09-30 |
| NCT02451592 |
Fungemia in Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02451592 |
Completed |
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne |
2015-12-31 |
| NCT02414022 |
Economic Analysis of Alliance A041202 CLL Study |
https://ClinicalTrials.gov/show/NCT02414022 |
Active, not recruiting |
Canadian Cancer Trials Group |
2019-04-05 |
| NCT02389972 |
Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study |
https://ClinicalTrials.gov/show/NCT02389972 |
Completed |
Bristol-Myers Squibb |
2017-07-13 |
| NCT02381899 |
Observational Study in CLL Patients Receiving BR |
https://ClinicalTrials.gov/show/NCT02381899 |
Completed |
Czech CLL Study Group |
2016-12-31 |
| NCT02378701 |
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease |
https://ClinicalTrials.gov/show/NCT02378701 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2023-02-28 |
| NCT02363868 |
Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population |
https://ClinicalTrials.gov/show/NCT02363868 |
Completed |
Bristol-Myers Squibb |
2014-11-30 |
| NCT02348957 |
Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib |
https://ClinicalTrials.gov/show/NCT02348957 |
Completed |
Onco Medical Consult GmbH |
2019-03-31 |
| NCT02344953 |
Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) |
https://ClinicalTrials.gov/show/NCT02344953 |
Recruiting |
Yonsei University |
2020-12-31 |
| NCT02338479 |
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02338479 |
Active, not recruiting |
Center for International Blood and Marrow Transplant Research |
2020-02-29 |
| NCT02303522 |
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) |
https://ClinicalTrials.gov/show/NCT02303522 |
Completed |
Amgen |
2015-01-22 |
| NCT02269592 |
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome |
https://ClinicalTrials.gov/show/NCT02269592 |
Recruiting |
Dana-Farber Cancer Institute |
2024-12-31 |
| NCT02272673 |
The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT02272673 |
Completed |
Ain Shams University |
2013-08-31 |
| NCT02222272 |
Effect of 2nd Gen TKI in CML |
https://ClinicalTrials.gov/show/NCT02222272 |
Completed |
European Group for Blood and Marrow Transplantation |
2014-03-19 |
| NCT02164903 |
LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT02164903 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2017-01-25 |
| NCT02110394 |
Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02110394 |
Completed |
Astellas Pharma Inc |
2015-08-31 |
| NCT02085798 |
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) |
https://ClinicalTrials.gov/show/NCT02085798 |
Completed |
Celgene |
2015-08-31 |
| NCT02080884 |
An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT02080884 |
Completed |
Hoffmann-La Roche |
2016-12-19 |
| NCT01311258 |
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01311258 |
Recruiting |
University of Rochester |
2020-08-31 |
| NCT01298414 |
Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01298414 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01295476 |
Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01295476 |
Completed |
Children’s Oncology Group |
2013-05-31 |
| NCT01290107 |
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01290107 |
Completed |
Children’s Oncology Group |
2015-01-31 |
| NCT01284010 |
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01284010 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-09-30 |
| NCT01278069 |
PET-CT in AML for Detection of Extramedullary AML Manifestations |
https://ClinicalTrials.gov/show/NCT01278069 |
Completed |
Technische Universität Dresden |
2013-09-30 |
| NCT02057185 |
Occupational Status and Hematological Disease |
https://ClinicalTrials.gov/show/NCT02057185 |
Active, not recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-03-31 |
| NCT02016833 |
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity |
https://ClinicalTrials.gov/show/NCT02016833 |
Completed |
PX Biosolutions |
2014-06-30 |
| NCT03310190 |
Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03310190 |
Recruiting |
AbbVie |
2021-06-30 |
| NCT02010931 |
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients |
https://ClinicalTrials.gov/show/NCT02010931 |
Completed |
Amgen |
2014-03-31 |
| NCT02003612 |
Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT02003612 |
Completed |
Amgen |
2014-01-31 |
| NCT01999556 |
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT01999556 |
Recruiting |
Atrium Health |
2021-09-30 |
| NCT01976442 |
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia |
https://ClinicalTrials.gov/show/NCT01976442 |
Completed |
University of Rochester |
2016-11-30 |
| NCT01965171 |
Transfusional Iron Overload Among Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT01965171 |
Completed |
St. Jude Children’s Research Hospital |
2017-05-31 |
| NCT01941680 |
High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant |
https://ClinicalTrials.gov/show/NCT01941680 |
Active, not recruiting |
University Hospital Center of Martinique |
2018-02-28 |
| NCT01929408 |
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients |
https://ClinicalTrials.gov/show/NCT01929408 |
Completed |
Fred Hutchinson Cancer Research Center |
2018-12-04 |
| NCT01913093 |
N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT01913093 |
Active, not recruiting |
The Hospital for Sick Children |
2018-01-31 |
| NCT01910623 |
Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01910623 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2014-07-31 |
| NCT01896752 |
Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL |
https://ClinicalTrials.gov/show/NCT01896752 |
Completed |
Rigshospitalet, Denmark |
2013-01-31 |
| NCT01886651 |
The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01886651 |
Completed |
Rigshospitalet, Denmark |
2012-02-29 |
| NCT01860456 |
TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study |
https://ClinicalTrials.gov/show/NCT01860456 |
Active, not recruiting |
University of Pisa |
2021-05-31 |
| NCT01805843 |
Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01805843 |
Completed |
Medical University of Graz |
2015-06-30 |
| NCT01790152 |
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment |
https://ClinicalTrials.gov/show/NCT01790152 |
Recruiting |
Children’s Oncology Group |
2022-03-30 |
| NCT01761890 |
Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib |
https://ClinicalTrials.gov/show/NCT01761890 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01752062 |
Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors |
https://ClinicalTrials.gov/show/NCT01752062 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01728402 |
Pathogenesis of Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01728402 |
Enrolling by invitation |
OHSU Knight Cancer Institute |
2020-10-31 |
| NCT01708421 |
Symptom Clusters in Children With Leukemia |
https://ClinicalTrials.gov/show/NCT01708421 |
Completed |
Duke University |
2018-08-01 |
| NCT01699217 |
Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase |
https://ClinicalTrials.gov/show/NCT01699217 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2019-11-30 |
| NCT01688011 |
Connect® MDS/AML Disease Registry |
https://ClinicalTrials.gov/show/NCT01688011 |
Recruiting |
Celgene |
2022-12-12 |
| NCT01678508 |
Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01678508 |
Completed |
Rigshospitalet, Denmark |
2011-07-31 |
| NCT01664936 |
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes |
https://ClinicalTrials.gov/show/NCT01664936 |
Completed |
Memorial Sloan Kettering Cancer Center |
2018-04-03 |
| NCT01642121 |
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01642121 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01642069 |
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01642069 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01629745 |
Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial |
https://ClinicalTrials.gov/show/NCT01629745 |
Completed |
Children’s Oncology Group |
2012-08-31 |
| NCT01625143 |
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01625143 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01626183 |
Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01626183 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01609023 |
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01609023 |
Completed |
Hoffmann-La Roche |
2015-11-30 |
| NCT01608152 |
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors |
https://ClinicalTrials.gov/show/NCT01608152 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-12-31 |
| NCT01595295 |
Registry on Hypomethylating Agents in Myeloid Neoplasms |
https://ClinicalTrials.gov/show/NCT01595295 |
Recruiting |
Arbeitsgemeinschaft medikamentoese Tumortherapie |
2020-06-30 |
| NCT01581528 |
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01581528 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01576185 |
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01576185 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01575535 |
S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01575535 |
Completed |
Southwest Oncology Group |
2012-05-31 |
| NCT01565447 |
Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study |
https://ClinicalTrials.gov/show/NCT01565447 |
Active, not recruiting |
Oregon Health and Science University |
2020-12-31 |
| NCT01556386 |
Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01556386 |
Completed |
Seoul National University Hospital |
2012-03-31 |
| NCT01553162 |
Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01553162 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01540812 |
Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS |
https://ClinicalTrials.gov/show/NCT01540812 |
Completed |
PETHEMA Foundation |
2019-11-20 |
| NCT01540578 |
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01540578 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01537159 |
MRI Assessment of Leukemia Response to Therapy |
https://ClinicalTrials.gov/show/NCT01537159 |
Completed |
OHSU Knight Cancer Institute |
2018-12-31 |
| NCT00806325 |
Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00806325 |
Completed |
Ohio State University |
2010-02-28 |
| NCT01533168 |
Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01533168 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01520246 |
Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01520246 |
Completed |
Children’s Oncology Group |
2016-07-31 |
| NCT01511575 |
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder |
https://ClinicalTrials.gov/show/NCT01511575 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01507441 |
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial |
https://ClinicalTrials.gov/show/NCT01507441 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01505699 |
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01505699 |
Completed |
Eastern Cooperative Oncology Group |
2012-02-06 |
| NCT01503541 |
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin |
https://ClinicalTrials.gov/show/NCT01503541 |
Completed |
Southwest Oncology Group |
2012-06-30 |
| NCT01500499 |
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01500499 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01498302 |
Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01498302 |
Completed |
Children’s Oncology Group |
2016-07-31 |
| NCT03262974 |
Effect of Pharmacogenetics on Imatinib Plasma Level and Response |
https://ClinicalTrials.gov/show/NCT03262974 |
Active, not recruiting |
Assiut University |
2021-05-31 |
| NCT01490853 |
Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy |
https://ClinicalTrials.gov/show/NCT01490853 |
Completed |
Università degli Studi di Brescia |
2012-01-31 |
| NCT01488162 |
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01488162 |
Completed |
Hoffmann-La Roche |
2016-10-24 |
| NCT01475110 |
Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib |
https://ClinicalTrials.gov/show/NCT01475110 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01472107 |
Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy |
https://ClinicalTrials.gov/show/NCT01472107 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2018-12-31 |
| NCT01470924 |
Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 |
https://ClinicalTrials.gov/show/NCT01470924 |
Completed |
Region Örebro County |
NA |
| NCT01464047 |
Korean Post-marketing Surveillance for Sprycel® |
https://ClinicalTrials.gov/show/NCT01464047 |
Completed |
Bristol-Myers Squibb |
2015-08-31 |
| NCT01460238 |
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01460238 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-05-31 |
| NCT01453062 |
Phase IV Observational Study in Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01453062 |
Completed |
GlaxoSmithKline |
2012-11-30 |
| NCT01439217 |
Endothelial Function, Arterial Stiffness and Components |
https://ClinicalTrials.gov/show/NCT01439217 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-02-28 |
| NCT01438138 |
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01438138 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01434329 |
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01434329 |
Completed |
Southwest Oncology Group |
2015-12-31 |
| NCT01421875 |
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01421875 |
Completed |
Eastern Cooperative Oncology Group |
2011-10-17 |
| NCT01419496 |
Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01419496 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01407757 |
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 |
https://ClinicalTrials.gov/show/NCT01407757 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01395628 |
Cell Samples From Patients With Leukemia |
https://ClinicalTrials.gov/show/NCT01395628 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01395615 |
An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia |
https://ClinicalTrials.gov/show/NCT01395615 |
Completed |
Hoffmann-La Roche |
2009-10-31 |
| NCT01394666 |
Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML) |
https://ClinicalTrials.gov/show/NCT01394666 |
Completed |
Bristol-Myers Squibb |
2012-12-31 |
| NCT01385787 |
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01385787 |
Completed |
Center for International Blood and Marrow Transplant Research |
2017-05-31 |
| NCT01385150 |
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01385150 |
Completed |
Eastern Cooperative Oncology Group |
2012-02-03 |
| NCT01380587 |
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01380587 |
Completed |
Hospital Universitario Dr. Jose E. Gonzalez |
2012-09-30 |
| NCT01365975 |
Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study |
https://ClinicalTrials.gov/show/NCT01365975 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-12-31 |
| NCT01360125 |
S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy |
https://ClinicalTrials.gov/show/NCT01360125 |
Completed |
Southwest Oncology Group |
2015-12-31 |
| NCT01338974 |
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01338974 |
Completed |
Southwest Oncology Group |
2012-08-31 |
| NCT01321385 |
Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01321385 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT04446741 |
Molecular Diagnostic Platform for AML |
https://ClinicalTrials.gov/show/NCT04446741 |
Recruiting |
PETHEMA Foundation |
2022-10-31 |
| NCT04380441 |
Quality of Life Model for Older Patients With AML |
https://ClinicalTrials.gov/show/NCT04380441 |
Recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2022-05-31 |
| NCT04369287 |
Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT04369287 |
Recruiting |
Istituto Clinico Humanitas |
2020-10-15 |
| NCT04364451 |
Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. |
https://ClinicalTrials.gov/show/NCT04364451 |
Recruiting |
Aristotle University Of Thessaloniki |
2022-08-31 |
| NCT04337138 |
A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World |
https://ClinicalTrials.gov/show/NCT04337138 |
Active, not recruiting |
Pfizer |
2020-07-31 |
| NCT04322084 |
Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL) |
https://ClinicalTrials.gov/show/NCT04322084 |
Recruiting |
St. Jude Children’s Research Hospital |
2021-05-01 |
| NCT04296214 |
Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT04296214 |
Recruiting |
Grupo Cooperativo de HemopatÃas Malignas |
2021-12-31 |
| NCT04271215 |
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT04271215 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2020-12-31 |
| NCT04259372 |
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT04259372 |
Completed |
University of Freiburg |
2019-12-31 |
| NCT04253314 |
A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation |
https://ClinicalTrials.gov/show/NCT04253314 |
Recruiting |
AbbVie |
2023-10-17 |
| NCT04251754 |
The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project |
https://ClinicalTrials.gov/show/NCT04251754 |
Recruiting |
The University of Hong Kong |
2025-01-31 |
| NCT04198415 |
A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) |
https://ClinicalTrials.gov/show/NCT04198415 |
Recruiting |
AbbVie |
2022-03-31 |
| NCT04187248 |
The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 |
https://ClinicalTrials.gov/show/NCT04187248 |
Completed |
Aarhus University Hospital |
2016-02-28 |
| NCT04178317 |
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT04178317 |
Recruiting |
AbbVie |
2026-03-25 |
| NCT04159779 |
A Study of Clinical Outcomes in Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece |
https://ClinicalTrials.gov/show/NCT04159779 |
Recruiting |
AbbVie |
2020-11-25 |
| NCT04158011 |
A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells |
https://ClinicalTrials.gov/show/NCT04158011 |
Active, not recruiting |
Sheba Medical Center |
2020-03-01 |
| NCT04157569 |
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia |
https://ClinicalTrials.gov/show/NCT04157569 |
Recruiting |
Navy General Hospital, Beijing |
2024-12-31 |
| NCT04150471 |
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT04150471 |
Recruiting |
Seoul St. Mary’s Hospital |
2020-12-30 |
| NCT04104035 |
Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response |
https://ClinicalTrials.gov/show/NCT04104035 |
Recruiting |
Ankara University |
2021-01-31 |
| NCT04089839 |
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting |
https://ClinicalTrials.gov/show/NCT04089839 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-10-31 |
| NCT04055558 |
Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma |
https://ClinicalTrials.gov/show/NCT04055558 |
Recruiting |
Rabin Medical Center |
2019-12-18 |
| NCT04037189 |
Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT04037189 |
Recruiting |
Rabin Medical Center |
2021-07-28 |
| NCT04028531 |
Understanding Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT04028531 |
Recruiting |
Dana-Farber Cancer Institute |
2024-09-29 |
| NCT04024241 |
Medium Dose of Cytarabine and Mitoxantrone |
https://ClinicalTrials.gov/show/NCT04024241 |
Recruiting |
Shenzhen People’s Hospital |
2019-08-31 |
| NCT03985826 |
Primary Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia |
https://ClinicalTrials.gov/show/NCT03985826 |
Completed |
University of Aarhus |
2019-11-30 |
| NCT03987958 |
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) |
https://ClinicalTrials.gov/show/NCT03987958 |
Recruiting |
AbbVie |
2023-07-01 |
| NCT03974893 |
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03974893 |
Recruiting |
Columbia University |
2021-11-30 |
| NCT03971565 |
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03971565 |
Recruiting |
Assistance Publique Hopitaux De Marseille |
2021-03-18 |
| NCT03933852 |
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose |
https://ClinicalTrials.gov/show/NCT03933852 |
Recruiting |
University of Jena |
2022-12-31 |
| NCT03921047 |
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03921047 |
Recruiting |
University of Southern California |
2022-02-01 |
| NCT03918655 |
MIF Involvement in AML |
https://ClinicalTrials.gov/show/NCT03918655 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-10-31 |
| NCT03911128 |
A Treatment Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia |
https://ClinicalTrials.gov/show/NCT03911128 |
Recruiting |
Karolinska University Hospital |
2020-03-31 |
| NCT03898128 |
ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate |
https://ClinicalTrials.gov/show/NCT03898128 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-10-31 |
| NCT03894852 |
SRSF2 Gene Mutation in Patients With t-MDS/AML |
https://ClinicalTrials.gov/show/NCT03894852 |
Completed |
Assiut University |
2019-12-29 |
| NCT03885076 |
Gamma Delta T Cells in AML |
https://ClinicalTrials.gov/show/NCT03885076 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2020-03-31 |
| NCT03885830 |
Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients |
https://ClinicalTrials.gov/show/NCT03885830 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-12-31 |
| NCT03881826 |
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03881826 |
Recruiting |
Université Catholique de Louvain |
2020-05-31 |
| NCT03873857 |
A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation |
https://ClinicalTrials.gov/show/NCT03873857 |
Recruiting |
AbbVie |
2022-12-03 |
| NCT03860376 |
Ex Vivo Drug Sensitivity Testing and Mutation Profiling |
https://ClinicalTrials.gov/show/NCT03860376 |
Recruiting |
Florida International University |
2022-12-15 |
| NCT03847727 |
Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03847727 |
Active, not recruiting |
Pirogov Russian National Research Medical University |
2019-12-03 |
| NCT03803670 |
Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT03803670 |
Completed |
University of Rome Tor Vergata |
2019-01-01 |
| NCT03789981 |
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03789981 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2021-12-31 |
| NCT03756675 |
Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03756675 |
Recruiting |
Peking University People’s Hospital |
2023-11-01 |
| NCT03755856 |
Long-term Outcomes for Acute Myeloid Leukemia Patients |
https://ClinicalTrials.gov/show/NCT03755856 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2021-06-30 |
| NCT03751072 |
Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) |
https://ClinicalTrials.gov/show/NCT03751072 |
Recruiting |
Group for Research in Adult Acute Lymphoblastic Leukemia |
2018-11-30 |
| NCT03735797 |
Cancer Stem Cells in Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03735797 |
Recruiting |
Sanford Health |
2022-07-01 |
| NCT03728699 |
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy |
https://ClinicalTrials.gov/show/NCT03728699 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2025-02-28 |
| NCT03720561 |
A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting |
https://ClinicalTrials.gov/show/NCT03720561 |
Active, not recruiting |
Janssen-Cilag S.p.A. |
2021-10-31 |
| NCT03719183 |
Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AML |
https://ClinicalTrials.gov/show/NCT03719183 |
Enrolling by invitation |
Assiut University |
2020-12-31 |
| NCT03709017 |
Iclusig PMS in CML or Ph+ALL Patients |
https://ClinicalTrials.gov/show/NCT03709017 |
Recruiting |
Korea Otsuka Pharmaceutical Co., Ltd. |
2023-06-30 |
| NCT03678454 |
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium |
https://ClinicalTrials.gov/show/NCT03678454 |
Recruiting |
Incyte Corporation |
2022-03-31 |
| NCT03659669 |
A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03659669 |
Recruiting |
AbbVie |
2024-10-31 |
| NCT03659084 |
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03659084 |
Recruiting |
Hospices Civils de Lyon |
2018-04-30 |
| NCT03647215 |
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey |
https://ClinicalTrials.gov/show/NCT03647215 |
Recruiting |
Incyte Corporation |
2020-06-30 |
| NCT03624686 |
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies |
https://ClinicalTrials.gov/show/NCT03624686 |
Recruiting |
National Taiwan University Hospital |
2020-12-31 |
| NCT03600558 |
Efficacy of FLAG Regimen for the Treatment of Patients With AML |
https://ClinicalTrials.gov/show/NCT03600558 |
Recruiting |
Tianjin Medical University General Hospital |
2020-07-31 |
| NCT03581045 |
Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals |
https://ClinicalTrials.gov/show/NCT03581045 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2020-06-30 |
| NCT03582098 |
Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland |
https://ClinicalTrials.gov/show/NCT03582098 |
Completed |
Gilead Sciences |
2019-03-26 |
| NCT03568266 |
Pharmacogenomics of Asparaginase Induced Hepatotoxicity |
https://ClinicalTrials.gov/show/NCT03568266 |
Recruiting |
University of Southern California |
2024-05-22 |
| NCT03545659 |
Childhood Acute Lymphoblastic Leukaemia: Follow-Up |
https://ClinicalTrials.gov/show/NCT03545659 |
Recruiting |
University of Aarhus |
2020-06-30 |
| NCT03540654 |
Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach |
https://ClinicalTrials.gov/show/NCT03540654 |
Completed |
University Hospital, Bordeaux |
2018-10-31 |
| NCT03537560 |
Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML |
https://ClinicalTrials.gov/show/NCT03537560 |
Enrolling by invitation |
Chang Gung Memorial Hospital |
2019-09-30 |
| NCT03528941 |
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib |
https://ClinicalTrials.gov/show/NCT03528941 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2020-08-31 |
| NCT03529760 |
Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia |
https://ClinicalTrials.gov/show/NCT03529760 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2019-07-15 |
| NCT03529227 |
Gazyva Infusion Reaction Investigation |
https://ClinicalTrials.gov/show/NCT03529227 |
Recruiting |
Healthy Future |
2019-03-31 |
| NCT03526926 |
A Post-Marketing Observational Study of VYXEOSâ„¢ |
https://ClinicalTrials.gov/show/NCT03526926 |
Active, not recruiting |
Jazz Pharmaceuticals |
2020-01-31 |
| NCT03488862 |
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients |
https://ClinicalTrials.gov/show/NCT03488862 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2020-10-01 |
| NCT03481868 |
EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors |
https://ClinicalTrials.gov/show/NCT03481868 |
Recruiting |
University Hospital, Clermont-Ferrand |
2021-02-10 |
| NCT03471416 |
Nutritional Status in Children With ALL in Guatemala |
https://ClinicalTrials.gov/show/NCT03471416 |
Recruiting |
Columbia University |
2021-01-31 |
| NCT03476655 |
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India |
https://ClinicalTrials.gov/show/NCT03476655 |
Completed |
Johnson & Johnson Private Limited |
2019-05-14 |
| NCT03466944 |
PUMA (Paediatric Osseous Marrow Assessment) |
https://ClinicalTrials.gov/show/NCT03466944 |
Recruiting |
Institute of Cancer Research, United Kingdom |
2020-12-31 |
| NCT03454503 |
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt |
https://ClinicalTrials.gov/show/NCT03454503 |
Active, not recruiting |
Hikma Pharmaceuticals LLC |
2021-01-31 |
| NCT03450512 |
Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy |
https://ClinicalTrials.gov/show/NCT03450512 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2022-12-01 |
| NCT03435341 |
Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain |
https://ClinicalTrials.gov/show/NCT03435341 |
Active, not recruiting |
Celgene |
2020-02-28 |
| NCT03433521 |
Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03433521 |
Completed |
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz |
2019-01-15 |
| NCT03421626 |
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT03421626 |
Completed |
Cepheid |
2018-08-20 |
| NCT03422731 |
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy |
https://ClinicalTrials.gov/show/NCT03422731 |
Recruiting |
City of Hope Medical Center |
2023-02-06 |
| NCT03413644 |
Evaluation of ClearLLab Leukemia and Lymphoma Panels |
https://ClinicalTrials.gov/show/NCT03413644 |
Completed |
Beckman Coulter, Inc. |
2018-04-27 |
| NCT01252589 |
Patient Reported Outcomes in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01252589 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2013-09-30 |
| NCT01252485 |
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project |
https://ClinicalTrials.gov/show/NCT01252485 |
Recruiting |
University of Ulm |
NA |
| NCT01251159 |
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01251159 |
Completed |
Eastern Cooperative Oncology Group |
2009-06-15 |
| NCT01247584 |
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01247584 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01245231 |
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01245231 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01244750 |
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting |
https://ClinicalTrials.gov/show/NCT01244750 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-01-30 |
| NCT01232855 |
Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01232855 |
Completed |
Children’s Oncology Group |
2011-02-28 |
| NCT01232842 |
Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01232842 |
Completed |
Children’s Oncology Group |
2016-07-31 |
| NCT03436524 |
A Prognostic Tool for Early Stage CLL |
https://ClinicalTrials.gov/show/NCT03436524 |
Recruiting |
Oncology Institute of Southern Switzerland |
2020-02-28 |
| NCT01229124 |
RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01229124 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01229956 |
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01229956 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01224093 |
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) |
https://ClinicalTrials.gov/show/NCT01224093 |
Completed |
Hoffmann-La Roche |
2014-02-28 |
| NCT01215487 |
A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib |
https://ClinicalTrials.gov/show/NCT01215487 |
Recruiting |
University of British Columbia |
2022-01-31 |
| NCT01207843 |
Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias |
https://ClinicalTrials.gov/show/NCT01207843 |
Completed |
University of Zurich |
2011-04-30 |
| NCT01203033 |
Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) |
https://ClinicalTrials.gov/show/NCT01203033 |
Completed |
West Virginia University |
2012-09-30 |
| NCT01199562 |
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT01199562 |
Completed |
City of Hope Medical Center |
2013-12-31 |
| NCT01185886 |
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01185886 |
Active, not recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-06-30 |
| NCT01178086 |
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) |
https://ClinicalTrials.gov/show/NCT01178086 |
Completed |
Hoffmann-La Roche |
2015-06-30 |
| NCT01174615 |
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth |
https://ClinicalTrials.gov/show/NCT01174615 |
Recruiting |
University of Massachusetts, Worcester |
2099-12-31 |
| NCT01169363 |
Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy |
https://ClinicalTrials.gov/show/NCT01169363 |
Completed |
Eastern Cooperative Oncology Group |
2010-08-08 |
| NCT01150669 |
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia |
https://ClinicalTrials.gov/show/NCT01150669 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01150656 |
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01150656 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01150058 |
Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01150058 |
Completed |
Children’s Oncology Group |
2012-11-30 |
| NCT01148927 |
Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01148927 |
Completed |
University Health Network, Toronto |
2012-06-30 |
| NCT01146223 |
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01146223 |
Completed |
Children’s Oncology Group |
2011-06-30 |
| NCT01146210 |
Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01146210 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01145469 |
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy |
https://ClinicalTrials.gov/show/NCT01145469 |
Completed |
Eastern Cooperative Oncology Group |
2010-08-01 |
| NCT01142427 |
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01142427 |
Active, not recruiting |
Children’s Oncology Group |
2015-05-01 |
| NCT01144793 |
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias |
https://ClinicalTrials.gov/show/NCT01144793 |
Completed |
Stanford University |
2008-06-30 |
| NCT01139931 |
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01139931 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01139333 |
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01139333 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01138332 |
Biomarkers in Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01138332 |
Completed |
Children’s Oncology Group |
2010-03-31 |
| NCT01138319 |
Biomarkers in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01138319 |
Completed |
Children’s Oncology Group |
2010-03-31 |
| NCT01139320 |
Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin |
https://ClinicalTrials.gov/show/NCT01139320 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01139307 |
Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01139307 |
Completed |
Children’s Oncology Group |
2012-08-31 |
| NCT01138306 |
Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01138306 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01137825 |
Registry of Older Patients With Cancer |
https://ClinicalTrials.gov/show/NCT01137825 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2030-06-30 |
| NCT01137643 |
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT01137643 |
Active, not recruiting |
UNC Lineberger Comprehensive Cancer Center |
2040-07-31 |
| NCT01119586 |
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01119586 |
Completed |
Children’s Oncology Group |
2015-12-31 |
| NCT01117142 |
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01117142 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01110850 |
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water |
https://ClinicalTrials.gov/show/NCT01110850 |
Completed |
Northwell Health |
2018-05-31 |
| NCT01094392 |
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) |
https://ClinicalTrials.gov/show/NCT01094392 |
Recruiting |
Aarhus University Hospital |
2019-12-31 |
| NCT01081015 |
Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry |
https://ClinicalTrials.gov/show/NCT01081015 |
Completed |
Celgene |
2017-12-31 |
| NCT01059734 |
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01059734 |
Completed |
Southwest Oncology Group |
2012-06-30 |
| NCT01057290 |
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01057290 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01057199 |
Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01057199 |
Completed |
Children’s Oncology Group |
2010-06-30 |
| NCT01057095 |
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01057095 |
Completed |
Children’s Oncology Group |
2010-04-30 |
| NCT01047020 |
Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) |
https://ClinicalTrials.gov/show/NCT01047020 |
Completed |
St. Jude Children’s Research Hospital |
2013-04-30 |
| NCT01046305 |
Symptom Burden in Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT01046305 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT01035307 |
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 |
https://ClinicalTrials.gov/show/NCT01035307 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01030913 |
B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression |
https://ClinicalTrials.gov/show/NCT01030913 |
Recruiting |
Northwell Health |
2021-01-31 |
| NCT01034839 |
High-dose Cytarabine and Survival in AML |
https://ClinicalTrials.gov/show/NCT01034839 |
Completed |
University of Sao Paulo General Hospital |
2008-12-31 |
| NCT01028430 |
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging |
https://ClinicalTrials.gov/show/NCT01028430 |
Recruiting |
Northwell Health |
2021-01-31 |
| NCT01024127 |
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01024127 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01016379 |
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT01016379 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT01014195 |
Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT01014195 |
Completed |
St. Jude Children’s Research Hospital |
2014-10-31 |
| NCT01005368 |
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01005368 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT01005277 |
Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01005277 |
Active, not recruiting |
Children’s Oncology Group |
2100-01-31 |
| NCT01004965 |
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 |
https://ClinicalTrials.gov/show/NCT01004965 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2011-01-31 |
| NCT01004640 |
Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial |
https://ClinicalTrials.gov/show/NCT01004640 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2001-02-28 |
| NCT00996047 |
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers |
https://ClinicalTrials.gov/show/NCT00996047 |
Completed |
Southwest Oncology Group |
2012-01-31 |
| NCT00993694 |
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone |
https://ClinicalTrials.gov/show/NCT00993694 |
Completed |
Vanderbilt University Medical Center |
2009-12-31 |
| NCT00993135 |
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00993135 |
Completed |
Vanderbilt University Medical Center |
2009-12-31 |
| NCT00969891 |
Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00969891 |
Completed |
University of Copenhagen |
NA |
| NCT00964821 |
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00964821 |
Completed |
City of Hope Medical Center |
2013-05-31 |
| NCT00956475 |
Quality of Life in Younger Leukemia and Lymphoma Survivors |
https://ClinicalTrials.gov/show/NCT00956475 |
Completed |
Case Comprehensive Cancer Center |
2010-09-30 |
| NCT00954720 |
Observational Study of Iron Overload in Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT00954720 |
Completed |
Dana-Farber Cancer Institute |
2011-01-31 |
| NCT00947830 |
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00947830 |
Completed |
McMaster University |
2012-04-30 |
| NCT00920842 |
Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00920842 |
Completed |
Fred Hutchinson Cancer Research Center |
2011-07-31 |
| NCT00920738 |
Metabolic Syndrome in Childhood Cancer Survivors |
https://ClinicalTrials.gov/show/NCT00920738 |
Completed |
University of Minnesota |
2010-07-31 |
| NCT00919425 |
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00919425 |
Completed |
Southwest Oncology Group |
2012-01-31 |
| NCT00923507 |
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) |
https://ClinicalTrials.gov/show/NCT00923507 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00900224 |
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00900224 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2015-12-31 |
| NCT00900380 |
Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00900380 |
Completed |
Eastern Cooperative Oncology Group |
2013-12-30 |
| NCT00899899 |
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission |
https://ClinicalTrials.gov/show/NCT00899899 |
Completed |
Children’s Oncology Group |
2005-03-31 |
| NCT00899873 |
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 |
https://ClinicalTrials.gov/show/NCT00899873 |
Completed |
Eastern Cooperative Oncology Group |
2012-07-17 |
| NCT00899223 |
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes |
https://ClinicalTrials.gov/show/NCT00899223 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2020-12-31 |
| NCT00899795 |
Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00899795 |
Completed |
OHSU Knight Cancer Institute |
2010-10-31 |
| NCT00898469 |
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 |
https://ClinicalTrials.gov/show/NCT00898469 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT00899743 |
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00899743 |
Completed |
Southwest Oncology Group |
2009-06-30 |
| NCT00899652 |
DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00899652 |
Completed |
Children’s Oncology Group |
2005-09-30 |
| NCT00899171 |
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00899171 |
Completed |
Southwest Oncology Group |
2012-09-30 |
| NCT00899015 |
Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J |
https://ClinicalTrials.gov/show/NCT00899015 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00898755 |
Collecting and Storing Tissue From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898755 |
Completed |
Children’s Oncology Group |
2008-07-17 |
| NCT00899366 |
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00899366 |
Completed |
Eastern Cooperative Oncology Group |
2009-07-30 |
| NCT00898261 |
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00898261 |
Completed |
Eastern Cooperative Oncology Group |
2012-07-19 |
| NCT00898456 |
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00898456 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00898092 |
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00898092 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2012-12-31 |
| NCT00898079 |
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00898079 |
Completed |
Children’s Oncology Group |
2018-06-30 |
| NCT00897936 |
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00897936 |
Completed |
Eastern Cooperative Oncology Group |
2006-04-23 |
| NCT00897559 |
Study of Bone Marrow Samples From Patients With Acute Leukemia |
https://ClinicalTrials.gov/show/NCT00897559 |
Completed |
Eastern Cooperative Oncology Group |
2009-11-11 |
| NCT00897325 |
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00897325 |
Completed |
Children’s Oncology Group |
2019-12-31 |
| NCT00897078 |
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings |
https://ClinicalTrials.gov/show/NCT00897078 |
Completed |
Vanderbilt University |
2011-10-31 |
| NCT00896766 |
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00896766 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT00896701 |
Relationship Between Natural Killer Cells’ Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 |
https://ClinicalTrials.gov/show/NCT00896701 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-04-30 |
| NCT00898404 |
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate |
https://ClinicalTrials.gov/show/NCT00898404 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT00896129 |
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy |
https://ClinicalTrials.gov/show/NCT00896129 |
Completed |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2010-12-31 |
| NCT00890435 |
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial |
https://ClinicalTrials.gov/show/NCT00890435 |
Completed |
Children’s Oncology Group |
2009-08-31 |
| NCT00889031 |
Protocol to Obtain Blood Samples for Leukemia Research |
https://ClinicalTrials.gov/show/NCT00889031 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-03-09 |
| NCT00866671 |
Observational Study of Nelarabine in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT00866671 |
Completed |
GlaxoSmithKline |
2014-09-30 |
| NCT00897182 |
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00897182 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-03-31 |
| NCT04070807 |
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2 |
https://ClinicalTrials.gov/show/NCT04070807 |
Recruiting |
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
2020-12-31 |
| NCT03047083 |
Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review |
https://ClinicalTrials.gov/show/NCT03047083 |
Completed |
Astellas Pharma Inc |
2017-05-19 |
| NCT03294980 |
Chronic Lymphoid Leukaemia Observatory in Finistere Area, France |
https://ClinicalTrials.gov/show/NCT03294980 |
Recruiting |
University Hospital, Brest |
2025-11-30 |
| NCT01362985 |
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor |
https://ClinicalTrials.gov/show/NCT01362985 |
Completed |
Sanofi |
2014-07-31 |
| NCT03633045 |
Observational Study of Ibrutinib Use in CLL |
https://ClinicalTrials.gov/show/NCT03633045 |
Recruiting |
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health |
2021-09-30 |
| NCT03350152 |
Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience. |
https://ClinicalTrials.gov/show/NCT03350152 |
Completed |
Hospices Civils de Lyon |
2014-06-01 |
| NCT02344966 |
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia |
https://ClinicalTrials.gov/show/NCT02344966 |
Recruiting |
Yonsei University |
2021-02-28 |
| NCT00816114 |
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial |
https://ClinicalTrials.gov/show/NCT00816114 |
Recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT01519648 |
A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01519648 |
Completed |
National Hematological Society, Russia |
2013-09-30 |
| NCT01437202 |
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01437202 |
Completed |
Asan Medical Center |
2012-09-30 |
| NCT00801346 |
Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission |
https://ClinicalTrials.gov/show/NCT00801346 |
Completed |
Vanderbilt University Medical Center |
2016-04-30 |
| NCT04437420 |
Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 |
https://ClinicalTrials.gov/show/NCT04437420 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-09-30 |
| NCT03425591 |
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT03425591 |
Recruiting |
Janssen-Cilag Ltd. |
2022-05-22 |
| NCT03165851 |
Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT03165851 |
Completed |
Institute of Hematology & Blood Diseases Hospital |
2012-12-31 |
| NCT02915224 |
A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities |
https://ClinicalTrials.gov/show/NCT02915224 |
Active, not recruiting |
Hoffmann-La Roche |
2020-04-30 |
| NCT02856204 |
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02856204 |
Completed |
Stanford University |
2017-12-31 |
| NCT02733445 |
Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib |
https://ClinicalTrials.gov/show/NCT02733445 |
Completed |
Bristol-Myers Squibb |
2015-12-31 |
| NCT02581917 |
Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT02581917 |
Recruiting |
Wake Forest University Health Sciences |
2020-09-30 |
| NCT01087333 |
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment |
https://ClinicalTrials.gov/show/NCT01087333 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02188290 |
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation |
https://ClinicalTrials.gov/show/NCT02188290 |
Completed |
Kiadis Pharma |
2015-06-30 |
| NCT03595969 |
Association Between Mitochondrial DNA Content and Risk of Acute Leukemia |
https://ClinicalTrials.gov/show/NCT03595969 |
Completed |
Fourth Military Medical University |
2019-10-01 |
| NCT03415035 |
Study Venetoclax Effectiveness and Realâ€Life Treatment Management in Participants With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT03415035 |
Recruiting |
AbbVie |
2022-03-30 |
| NCT03526666 |
Ascorbic Acid Levels in MDS, AML, and CMML Patients |
https://ClinicalTrials.gov/show/NCT03526666 |
Completed |
Van Andel Research Institute |
2018-10-31 |
| NCT01076569 |
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01076569 |
Completed |
Children’s Oncology Group |
2016-05-31 |
| NCT00897507 |
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00897507 |
Active, not recruiting |
Children’s Oncology Group |
2100-01-31 |
| NCT00664131 |
Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors |
https://ClinicalTrials.gov/show/NCT00664131 |
Completed |
St. Jude Children’s Research Hospital |
2008-10-31 |
| NCT00632255 |
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment |
https://ClinicalTrials.gov/show/NCT00632255 |
Completed |
Imperial College London |
2009-05-31 |
| NCT00606216 |
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy |
https://ClinicalTrials.gov/show/NCT00606216 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-12-31 |
| NCT00569842 |
Investigation of the Cylex® ImmuKnow® Assay |
https://ClinicalTrials.gov/show/NCT00569842 |
Completed |
Indiana University |
2010-02-28 |
| NCT00552825 |
Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children |
https://ClinicalTrials.gov/show/NCT00552825 |
Completed |
Sheba Medical Center |
NA |
| NCT00525746 |
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) |
https://ClinicalTrials.gov/show/NCT00525746 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2025-03-31 |
| NCT00513175 |
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00513175 |
Completed |
University of California, San Francisco |
NA |
| NCT00510315 |
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT00510315 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT00504920 |
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients |
https://ClinicalTrials.gov/show/NCT00504920 |
Completed |
M.D. Anderson Cancer Center |
2008-09-30 |
| NCT00503256 |
Genetic Study of Chronic Lymphocytic Leukemia Families |
https://ClinicalTrials.gov/show/NCT00503256 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2019-09-30 |
| NCT00502983 |
Molecular Epidemiology of Acute Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00502983 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-09-30 |
| NCT00505141 |
Urban Environmental Exposures and Childhood Cancer |
https://ClinicalTrials.gov/show/NCT00505141 |
Completed |
Georgetown University |
NA |
| NCT00499785 |
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00499785 |
Completed |
Wake Forest University Health Sciences |
2009-01-31 |
| NCT00489632 |
Children’s Resiliency, Adjustment, and Coping |
https://ClinicalTrials.gov/show/NCT00489632 |
Completed |
M.D. Anderson Cancer Center |
2011-01-31 |
| NCT00481858 |
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis |
https://ClinicalTrials.gov/show/NCT00481858 |
Completed |
KineMed |
2010-07-31 |
| NCT00482352 |
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00482352 |
Completed |
Children’s Oncology Group |
2012-04-30 |
| NCT00459524 |
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
https://ClinicalTrials.gov/show/NCT00459524 |
Completed |
M.D. Anderson Cancer Center |
2009-03-31 |
| NCT00437060 |
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00437060 |
Completed |
Children’s Oncology Group |
2015-09-30 |
| NCT00429910 |
Natural History Study of Patients With Chronic Myelogenous Leukemia |
https://ClinicalTrials.gov/show/NCT00429910 |
Completed |
Dana-Farber Cancer Institute |
2005-09-30 |
| NCT01072240 |
An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia |
https://ClinicalTrials.gov/show/NCT01072240 |
Completed |
Hoffmann-La Roche |
2011-06-30 |
| NCT01057303 |
Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT01057303 |
Completed |
Children’s Oncology Group |
2010-06-30 |
| NCT00390715 |
Treatment of Acute Myeloblastic Leukemia in Younger Patients |
https://ClinicalTrials.gov/show/NCT00390715 |
Completed |
PETHEMA Foundation |
2007-12-31 |
| NCT00344825 |
Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) |
https://ClinicalTrials.gov/show/NCT00344825 |
Completed |
Sanofi |
2006-11-30 |
| NCT00341016 |
Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident |
https://ClinicalTrials.gov/show/NCT00341016 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-02-12 |
| NCT00339963 |
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00339963 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00339664 |
Analyses of Human Samples Collected in Clinical Trials |
https://ClinicalTrials.gov/show/NCT00339664 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-03-17 |
| NCT00330538 |
Osteoporosis in Children With ALL |
https://ClinicalTrials.gov/show/NCT00330538 |
Completed |
Children’s Mercy Hospital Kansas City |
NA |
| NCT00286845 |
Use of the MiCK Assay for Apoptosis in AML |
https://ClinicalTrials.gov/show/NCT00286845 |
Completed |
Pierian Biosciences |
NA |
| NCT00281814 |
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00281814 |
Completed |
The Cleveland Clinic |
2008-12-31 |
| NCT00277056 |
Dysregulated Tyrosine Kinase Signaling in Leukemia |
https://ClinicalTrials.gov/show/NCT00277056 |
Completed |
University of New Mexico |
2005-10-31 |
| NCT00281801 |
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation |
https://ClinicalTrials.gov/show/NCT00281801 |
Completed |
Case Comprehensive Cancer Center |
2008-12-31 |
| NCT00257647 |
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML) |
https://ClinicalTrials.gov/show/NCT00257647 |
Completed |
Hadassah Medical Organization |
NA |
| NCT00179868 |
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications |
https://ClinicalTrials.gov/show/NCT00179868 |
Completed |
Ann & Robert H Lurie Children’s Hospital of Chicago |
2008-02-29 |
| NCT00126477 |
Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00126477 |
Completed |
Fred Hutchinson Cancer Research Center |
2007-04-30 |
| NCT00186147 |
Bone Marrow Grafting for Leukemia and Lymphoma |
https://ClinicalTrials.gov/show/NCT00186147 |
Enrolling by invitation |
Stanford University |
2069-12-31 |
| NCT00159003 |
Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel |
https://ClinicalTrials.gov/show/NCT00159003 |
Completed |
Hadassah Medical Organization |
2017-07-01 |
| NCT00005619 |
Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia |
https://ClinicalTrials.gov/show/NCT00005619 |
Completed |
Northwestern University |
2001-08-31 |
| NCT00085176 |
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00085176 |
Completed |
Children’s Oncology Group |
2009-09-30 |
| NCT00002485 |
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer |
https://ClinicalTrials.gov/show/NCT00002485 |
Completed |
Children’s Oncology Group |
2003-07-31 |
| NCT00003790 |
Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00003790 |
Completed |
Children’s Oncology Group |
2002-04-30 |
| NCT00005881 |
Quality of Life in Children Treated for Cancer |
https://ClinicalTrials.gov/show/NCT00005881 |
Completed |
Children’s Oncology Group |
2003-03-31 |
| NCT00003931 |
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia |
https://ClinicalTrials.gov/show/NCT00003931 |
Completed |
Alliance for Clinical Trials in Oncology |
2006-06-30 |
| NCT00048958 |
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT00048958 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00003861 |
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia |
https://ClinicalTrials.gov/show/NCT00003861 |
Active, not recruiting |
Alliance for Clinical Trials in Oncology |
2100-01-31 |
| NCT00003793 |
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma |
https://ClinicalTrials.gov/show/NCT00003793 |
Completed |
Children’s Oncology Group |
2005-12-31 |
| NCT00003291 |
Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT00003291 |
Completed |
Children’s Oncology Group |
2006-03-31 |
| NCT00042445 |
Brain Neoplasms, Leukemia and Petrochemical Exposures |
https://ClinicalTrials.gov/show/NCT00042445 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
NA |
| NCT00015587 |
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) |
https://ClinicalTrials.gov/show/NCT00015587 |
Completed |
National Institute of Environmental Health Sciences (NIEHS) |
2016-07-31 |